Lumida
/HOWL
⌘K
Werewolf Therapeutics Inc

Werewolf Therapeutics Inc

HOWL
$0.98USD-0.66%-0.01 today

MARKET CAP

47.7M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$0
$2
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$0$16.4M$19.9M$1.9M
YoY %+21.6%-90.5%
P / Sales3.6x8.3x34.4x
EV / Sales-2.0x4.7x4.0x
Gross Profit, Adj.$0$16.4M$19.9M$1.9M
YoY %+21.6%-90.5%
Margin %100.0%100.0%100.0%
EV / Gross Profit-2.0x4.7x4.0x
EBITDA, Adj.$-49.9M$-53.5M$-38.7M$-71.8M
YoY %-7.4%+27.7%-85.3%
Margin %-326.5%-194.2%-3808.0%
EV / EBITDA-1.8x0.6x-2.4x-0.1x
EBIT$-50.1M$-56.1M$-40.5M$-73.6M
YoY %-11.9%+27.7%-81.7%
Margin %-341.8%-203.1%-3904.2%
EV / EBIT-1.8x0.6x-2.3x-0.1x
Net Income$-201.9M$-53.8M$-37.4M$-70.5M
YoY %+73.4%+30.6%-88.7%
Net Margin-328.1%-187.4%-3740.8%
EPS (GAAP)-$10.94-$1.86-$1.05-$1.63
YoY %+83.0%+43.5%-55.2%